Patent ID: 7202278
Filing Date: 2007-04-10
Classification: A61K,A61P,C07C

Abstract:
1. A pharmaceutical preparation, comprising an effective amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) at least one other pharmaceutical active compound chosen from statins, ACE-inhibitors, PDE V-inhibitors, Ca-antagonists, beta-blockers, arginine, and tetrahydrobiopterin; and a pharmaceutically acceptable carrier, wherein the pharmaceutical preparation is for the treatment of a mammal suffering from a disease chosen from stable and unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusive disease, endothelial dysfunction, atherosclerosis, restenosis, endothelial damage after PTCA, hypertension, chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, diabetes and diabetes complications, nephropathy and retinopathy, angiogenesis, asthma bronchiale, chronic renal failure, cirrhosis of the liver, osteoporosis, restricted memory performance, and a restricted ability to learn.